Branded Legacy Inc. BLEG Archives

MondayOct 27, 2025 9:30 am

QualityStocksNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Advances Engineering of Air-Driven Intranasal Drug Delivery Mold

Branded Legacy (OTC: BLEG), a leader in innovative addiction treatment and harm reduction solutions, announced that its subsidiary, BioLegacy Evaluative Group Inc., has begun engineering and development of a unitary device mold for its proprietary air-driven intranasal drug delivery platform. The milestone advances scalable production of its single-use device for rapid, reliable therapeutic delivery, including its flagship inhaled naloxone program. Building on a September 2025 provisional patent filing and the opening of a GMP-compliant facility in Vancouver, the development strengthens Branded Legacy’s capacity to address the opioid crisis through affordable, high-quality pharmaceutical solutions. To view the full press release, visit https://ibn.fm/e7yIt…

TuesdaySep 30, 2025 9:00 am

QualityStocksNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Subsidiary Files Provisional Patent for Intranasal Drug Delivery Platform

Branded Legacy (OTC: BLEG), a holding company focused on innovative life sciences and wellness solutions, announced that its subsidiary BioLegacy Evaluative Group Inc. has filed a provisional patent application with the U.S. Patent and Trademark Office for its “Air-Driven Unitary Intranasal Drug Delivery Device for Stable and Reconstitutable Medicaments,” a compact, air-powered platform designed to provide precise, reliable, and cost-effective intranasal dosing for both stable formulations such as naloxone and unstable drugs requiring on-demand reconstitution. To view the full press release, visit https://ibn.fm/2uKdJ About Branded Legacy, Inc. Branded Legacy, Inc. (OTC: BLEG) is a forward-thinking holdings company dedicated to pioneering solutions in…

ThursdaySep 04, 2025 9:30 am

QualityStocksNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Subsidiary Acquires 22,000-Square-Foot Facility to Advance Addiction Treatment Solutions

Branded Legacy (OTC: BLEG), a biotechnology company focused on addiction treatment and harm reduction, announced that its subsidiary, BioLegacy Evaluative Group, has acquired a 22,000-square-foot commercial property in Vancouver, Canada. The new GMP-compliant facility, equipped with ISO Class 7 and 8 clean rooms, will serve as a laboratory and manufacturing hub to support the development of safe, effective devices and products designed to counteract hazardous substances and reduce associated harms. Strategically located in the center of Vancouver’s drug crisis, the site will enable BioLegacy to collaborate directly with affected populations while advancing technologies supported by partnerships with McMaster University and Stanford…

TuesdayAug 19, 2025 12:55 pm

QualityStocksNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Subsidiary Forms Strategic Partnership With McMaster University

Branded Legacy (OTC: BLEG), a diversified holdings company focused on health and wellness solutions, announced that its wholly owned subsidiary, Bio-Legacy Evaluative Group, has partnered with McMaster University to evaluate innovative products for populations affected by addictions. The collaboration will combine McMaster’s expertise in addiction medicine, clinical trials, and guideline development with Bio-Legacy’s real-world scientific experience to advance rigorous evaluations, clinical trials, and regulatory submissions, supporting the development of accessible, cost-effective interventions aimed at reducing overdose deaths, minimizing drug-related harms, and promoting long-term recovery. To view the full press release, visit https://ibn.fm/qF5UU About Branded Legacy, Inc. Branded Legacy, Inc. (OTC: BLEG) is…

TuesdayAug 12, 2025 9:35 am

QualityStocksNewsBreaks – InvestorNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Completes Acquisition of Bio Legacy Evaluative Group, Expanding into Biotech and Medical Devices

Branded Legacy (OTC: BLEG), a diversified holdings company in the health and wellness sector, has completed its acquisition of Bio Legacy Evaluative Group, formerly Menlo Health, in an all-stock deal valued at $1.5 million in Preferred D shares. The transaction, closed July 31, 2025, positions Branded Legacy to address global health challenges such as the addiction epidemic and vaccine distribution inefficiencies. Under CEO Amin Janmohamed, Bio Legacy brings a patented all-in-one intranasal naloxone device targeting a market projected to grow from $371 million in 2022 to over $1.16 billion by 2032, along with technology for nasal delivery of vaccines and cold-chain…

MondayJul 14, 2025 2:10 pm

QualityStocksNewsBreaks – Announces Leadership Overhaul and Strategic Merger in Addiction Therapeutics

Branded Legacy (OTC: BLEG), a diversified holdings firm, announced a full leadership transition and a pending merger aimed at entering the addiction therapeutics space. Interim CEO Jeffery Robison now leads the company following the resignation of the entire prior management team. A Letter of Intent has been submitted for a merger with a company specializing in advanced intranasal drug delivery, including a patented all-in-one naloxone device. The combined entity projects $40 million in first-year revenue and aims to disrupt the opioid overdose and broader addiction treatment markets with scalable, cost-effective solutions. Merger closing is expected within two weeks, pending approvals. To…

Site Search

Company Search

Tag: Branded Legacy Inc. BLEG

QualityStocksNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Advances Engineering of Air-Driven Intranasal Drug Delivery Mold

QualityStocksNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Subsidiary Files Provisional Patent for Intranasal Drug Delivery Platform

QualityStocksNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Subsidiary Acquires 22,000-Square-Foot Facility to Advance Addiction Treatment Solutions

QualityStocksNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Subsidiary Forms Strategic Partnership With McMaster University

QualityStocksNewsBreaks – InvestorNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Completes Acquisition of Bio Legacy Evaluative Group, Expanding into Biotech and Medical Devices

QualityStocksNewsBreaks – Announces Leadership Overhaul and Strategic Merger in Addiction Therapeutics

Market Basics

Newsletter Publishers

Public Companies